Lista de obras -

A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling

artículo científico publicado en 2006

A modular transcriptome map of mature B cell lymphomas

article

A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL

artículo científico publicado en 2019

A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile

artículo científico publicado en 2022

ATM activity in T cells is critical for immune surveillance of lymphoma in vivo

scientific article published on 05 November 2019

Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYC.

artículo científico

Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis

artículo científico publicado en 2016

Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma

artículo científico publicado en 2013

Blastoid and pleomorphic mantle cell lymphoma: still a diagnostic and therapeutic challenge!

artículo científico publicado en 2018

CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma

artículo científico publicado en 2012

Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group

artículo científico

Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy

artículo científico publicado en 2016

Cytokeratin Expression in Plasmablastic Lymphoma - a Possible Diagnostic Pitfall in the Routine Work-Up of Tumors

artículo científico publicado en 2020

Excellent outcome with limited treatment in paediatric patients with marginal zone lymphoma

artículo científico publicado en 2017

Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group

scientific article published on 02 April 2020

Expression of ELF1, a lymphoid ETS domain-containing transcription factor, is recurrently lost in classical Hodgkin lymphoma

scientific article published on 25 January 2019

Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network.

artículo científico publicado en 2017

FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy.

artículo científico publicado en 2017

Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma

artículo científico publicado en 2008

Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2.

artículo científico publicado en 2018

Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma--a matched pair analysis from the German Hodgkin Study Group (GHSG).

artículo científico publicado en 2014

Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL.

artículo científico publicado en 2010

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry

artículo científico publicado en 2015

Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.

artículo científico publicado en 2013

Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials

artículo científico publicado en 2009

MINCR is a MYC-induced lncRNA able to modulate MYC's transcriptional network in Burkitt lymphoma cells

artículo científico publicado en 2015

MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma ⬇️

artículo científico publicado el 18 de enero de 2013

Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status

article

Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial: correlation with interim PET and outcome

artículo científico publicado en 2019

New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling

artículo científico publicado en 2008

Novel IGH and MYC Translocation Partners in Diffuse Large B-Cell Lymphomas

artículo científico publicado en 2016

Platform independent protein-based cell-of-origin subtyping of diffuse large B-cell lymphoma in formalin-fixed paraffin-embedded tissue

artículo científico publicado en 2020

Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing

artículo científico publicado en 2012

T-Cell Clustering in Neoplastic Follicles of Follicular Lymphoma

scientific article published on 11 September 2018

TP53 mutation and survival in aggressive B cell lymphoma

artículo científico publicado en 2017

TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma

artículo científico publicado en 2018

The impact of SOCS1 mutations in diffuse large B-cell lymphoma

scientific article published on 12 August 2019

The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)

artículo científico publicado en 2013

Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network

article

Lista de obras de

A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling

A modular transcriptome map of mature B cell lymphomas

A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL

A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile

ATM activity in T cells is critical for immune surveillance of lymphoma in vivo

Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYC.

Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis

Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma

Blastoid and pleomorphic mantle cell lymphoma: still a diagnostic and therapeutic challenge!

CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma

Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group

Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy

Cytokeratin Expression in Plasmablastic Lymphoma - a Possible Diagnostic Pitfall in the Routine Work-Up of Tumors

Excellent outcome with limited treatment in paediatric patients with marginal zone lymphoma

Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group

Expression of ELF1, a lymphoid ETS domain-containing transcription factor, is recurrently lost in classical Hodgkin lymphoma

Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network.

FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy.

Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma

Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2.

Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma--a matched pair analysis from the German Hodgkin Study Group (GHSG).

Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL.

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry

Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.

Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials

MINCR is a MYC-induced lncRNA able to modulate MYC's transcriptional network in Burkitt lymphoma cells

MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma ⬇️

Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status

Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial: correlation with interim PET and outcome

New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling

Novel IGH and MYC Translocation Partners in Diffuse Large B-Cell Lymphomas

Platform independent protein-based cell-of-origin subtyping of diffuse large B-cell lymphoma in formalin-fixed paraffin-embedded tissue

Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing

T-Cell Clustering in Neoplastic Follicles of Follicular Lymphoma

TP53 mutation and survival in aggressive B cell lymphoma

TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma

The impact of SOCS1 mutations in diffuse large B-cell lymphoma

The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)

Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network